Silent Epidemic: One Person Dies Weekly in England From Undetected Tuberculosis

One Death Per Week: England's Hidden Tuberculosis Crisis

A sobering new study has revealed that at least one person every week in England dies from tuberculosis that was never detected while they were alive — meaning they received no treatment and had no chance of survival from a disease that is both preventable and curable.

Researchers behind the findings say the pattern of these posthumous diagnoses is raising serious questions about gaps in clinical awareness, particularly among healthcare professionals who may not be considering TB as a possibility in certain patient groups.

Older, British-Born Men Are Slipping Through the Cracks

The study, published in the medical journal Thorax, uncovered a striking demographic pattern. While the majority of tuberculosis cases in England are typically identified in people born outside the UK — with an average age of around 36 — those receiving a diagnosis only after death tended to be older and British-born.

This contrast suggests that medical professionals may be unconsciously filtering out the possibility of TB in patients who don't match the conventional risk profile. The research also found that men living outside London and those with a history of drug or alcohol misuse faced a higher likelihood of going undiagnosed before death.

Younger children under the age of four were also flagged as a vulnerable group. Researchers attributed this to factors including underdeveloped immune systems, vague and non-specific symptoms, and the practical difficulties involved in collecting suitable test samples from very young patients.

A 'Never Event' That Demands Urgent Action

Dr. Eleanor Morgan, co-author of the study and a resident physician at Liverpool University Hospitals NHS Foundation Trust, emphasized the need for a broader mindset shift in clinical settings.

"As TB rates continue to rise, we need to keep asking: 'Could this be TB?' — even in people who do not fit the usual risk profiles," she said. "If England is to eliminate TB, reducing delays in diagnosis will be essential so that fewer people miss the opportunity to receive effective treatment."

The research team described a postmortem TB diagnosis as the "ultimate diagnostic delay" and called for it to be treated as a "never event" — a classification used in the NHS for serious, preventable incidents that demand immediate investigation and systemic review.

Dr. Tom Wingfield of the Liverpool School of Tropical Medicine, the paper's senior author, drew a parallel with how the NHS handles deaths linked to drug-resistant bacteria such as MRSA. He argued that TB fatalities should trigger the same level of root cause analysis to identify where care fell short and prevent similar deaths from occurring in the future.

"TB deaths should trigger learning, not blame, so that services can identify where opportunities were missed and prevent the next avoidable death," Wingfield said.

England's TB Rates Are at a Decade High

The study arrives at a particularly concerning moment. Tuberculosis rates across England have climbed to their highest level in ten years, reaching 9.4 cases per 100,000 people in 2024. That figure sits just beneath the World Health Organization's benchmark of 10 cases per 100,000, a threshold that experts warn is likely to be surpassed once 2025 data becomes available.

Delayed diagnoses carry consequences that extend well beyond the individual patient. Late detection leads to worse health outcomes, greater social and economic burden, and extended windows during which the disease can be transmitted to others in the community.

Dr. Paul Cleary, a consultant epidemiologist at the UK Health Security Agency and a co-author of the study, noted that whether a patient died directly from TB or simply had the disease at the time of death, both scenarios likely represent missed chances to intervene earlier and prevent further spread.

A Global Disease With Local Consequences

Tuberculosis remains the deadliest infectious disease on the planet. In 2024 alone, an estimated 1.23 million people died from TB globally, while approximately 10.7 million fell ill. Despite this, it is a disease for which effective treatments exist, and recent medical advances have significantly shortened the duration of treatment — even for drug-resistant strains.

The global picture has been further complicated by disruptions caused during the COVID-19 pandemic, which severely hampered TB detection and treatment programmes worldwide. Experts are now raising fresh concerns that significant aid cuts by the United States and other major donor nations could once again set back progress in controlling the disease internationally.

Dr. Wingfield was careful to frame the situation as serious but manageable. "TB is preventable, treatable and curable," he stressed, urging calm while calling for decisive improvements in early detection and diagnostic vigilance across England's healthcare system.